ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2,1,Tongue coated,Tongue signs and symptoms,Tongue conditions,Gastr,N
3,1,Radial nerve palsy,Mononeuropathies,Peripheral neuropathies,Nerv,N
4,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
5,1,Tonic convulsion,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
6,1,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
6,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
6,3,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
6,5,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
7,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
7,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
7,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
7,4,Headache,Headaches NEC,Headaches,Nerv,N
7,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
8,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
8,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
8,3,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
8,4,Sneezing,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
8,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
9,1,Hypotonia,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
9,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
10,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
10,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
11,1,Eclampsia,Hypertension associated disorders of pregnancy,Maternal complications of pregnancy,Preg,N
12,1,Eclampsia,Hypertension associated disorders of pregnancy,Maternal complications of pregnancy,Preg,N
13,1,Peripheral ischaemia,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
14,1,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
15,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
16,1,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
17,1,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
18,1,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
19,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
20,1,Ventricular fibrillation,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
21,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
22,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
22,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
22,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
22,4,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
22,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
23,1,Ventricular fibrillation,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
24,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
25,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
26,1,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
27,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
28,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
28,2,Sedation,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
28,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
29,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
29,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
30,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
31,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
32,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
32,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
33,1,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
34,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
34,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
35,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
35,2,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
36,1,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
37,1,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
38,1,Cardiac arrest neonatal,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
39,1,Dystonia,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
40,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
40,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
40,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
41,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
42,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
42,2,Ventricular tachycardia,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
43,1,Ventricular fibrillation,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
44,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
44,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
44,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
44,4,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
45,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
45,2,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
45,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
45,4,Pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
46,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
46,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
47,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
47,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
48,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
49,1,Glossodynia,Tongue signs and symptoms,Tongue conditions,Gastr,N
49,2,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
50,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
51,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
51,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
51,3,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
52,1,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
52,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
52,3,Miliaria,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
53,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
54,1,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
54,2,Gingival bleeding,Gingival haemorrhages,Dental and gingival conditions,Gastr,N
55,1,Accidental exposure to product by child,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
55,2,Coma scale abnormal,Neurologic diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
55,3,Miosis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
55,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
56,1,Head injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
56,2,Psychotic behaviour,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
56,3,Substance abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
56,4,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
57,1,Headache,Headaches NEC,Headaches,Nerv,N
57,2,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
58,1,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
58,2,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
58,3,Myocardial ischaemia,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
58,4,Nephropathy,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
58,5,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
59,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
60,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
60,2,Muscle contractions involuntary,Neuromuscular disorders NEC,Neuromuscular disorders,Nerv,N
60,3,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
60,4,Obstructive airways disorder,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
60,5,Salivary hypersecretion,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
60,6,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
60,7,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
61,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
61,2,Motion sickness,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
61,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
61,4,Tension headache,Headaches NEC,Headaches,Nerv,N
62,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
62,2,Headache,Headaches NEC,Headaches,Nerv,N
62,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
62,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
63,1,Substance abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
63,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
64,1,Head discomfort,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
64,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
64,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
64,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
65,1,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
65,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
65,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
65,4,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
65,5,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
65,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
65,7,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
66,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
66,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
66,3,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
67,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
67,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
67,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
68,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
68,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
68,3,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
69,1,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
70,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
70,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
70,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
70,4,Panic reaction,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
70,5,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
70,6,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
70,7,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
71,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
71,2,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
71,3,Nasal dryness,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
71,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
71,5,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
71,6,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
72,1,Substance abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
73,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
73,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
73,3,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
73,4,Headache,Headaches NEC,Headaches,Nerv,N
73,5,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
73,6,Pericarditis,Noninfectious pericarditis,Pericardial disorders,Card,N
74,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
75,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
75,2,Delirium,Deliria,Deliria (incl confusion),Psych,N
75,3,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
75,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
76,1,Gastroenteritis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
77,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
77,2,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
78,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
78,2,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
78,3,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
79,1,Headache,Headaches NEC,Headaches,Nerv,N
79,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
79,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
80,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
80,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
80,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
80,4,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
81,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
81,2,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
81,3,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
81,4,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
82,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
83,1,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
83,2,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
84,1,Drug withdrawal syndrome neonatal,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
84,2,Foetal cystic hygroma,Congenital disorders NEC,Congenital and hereditary disorders NEC,Cong,N
84,3,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
84,4,Micrognathia,"Musculoskeletal and connective tissue disorders of face, neck and jaw congenital",Musculoskeletal and connective tissue disorders congenital,Cong,N
84,5,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
84,6,Poor sucking reflex,Abnormal reflexes,Neurological disorders NEC,Nerv,N
84,7,Regurgitation,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
85,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
85,2,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
86,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
87,1,Chest wall abscess,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,N
87,2,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
88,1,Chest wall abscess,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,N
88,2,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
89,1,Migraine,Migraine headaches,Headaches,Nerv,N
90,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
90,2,Migraine,Migraine headaches,Headaches,Nerv,N
90,3,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
91,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
92,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
93,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
93,2,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
93,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
93,4,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
94,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
94,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
95,1,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
96,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
96,2,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
97,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
97,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
97,3,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
97,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
97,5,Yawning,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
98,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
98,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
98,3,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
98,4,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
98,5,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
98,6,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
99,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
99,2,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
99,3,Headache,Headaches NEC,Headaches,Nerv,N
99,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
100,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
100,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
100,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
100,4,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
101,1,Homicidal ideation,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
101,2,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
101,3,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
102,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
102,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
102,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
102,4,Headache,Headaches NEC,Headaches,Nerv,N
102,5,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
102,6,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
102,7,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
103,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
103,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
103,3,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
104,1,Slow response to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
104,2,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
105,1,Blood glucose decreased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
105,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
106,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
106,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
106,3,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
106,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
106,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
107,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
107,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
107,3,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
107,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
107,5,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
107,6,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
107,7,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
107,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
107,9,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
107,10,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
107,11,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
108,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
108,2,Body temperature decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
108,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
108,4,Defaecation urgency,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
108,5,Parosmia,Olfactory nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
109,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
109,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
110,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
110,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
110,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
110,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
111,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
112,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
112,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
112,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
112,4,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
113,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
113,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
114,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
114,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
114,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
115,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
115,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
116,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
116,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
117,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
117,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
118,1,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
118,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
118,3,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
118,4,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
118,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
119,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
119,2,Cardiac failure,Heart failures NEC,Heart failures,Card,N
120,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
120,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
120,3,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
121,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
121,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
122,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
123,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
124,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
125,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
125,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
126,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
126,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
127,1,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
128,1,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
128,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
129,1,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
130,1,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
131,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
131,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
131,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
131,4,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
131,5,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
131,6,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
131,7,Parosmia,Olfactory nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
132,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
132,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
132,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
133,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
133,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
134,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
134,2,Substance abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
134,3,Suicide attempt,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
135,1,Joint dislocation,Fractures and dislocations NEC,Bone and joint injuries,Inj&P,N
135,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
135,3,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
136,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
137,1,Therapeutic product ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
137,2,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
138,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
138,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
138,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
139,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
140,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
140,2,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
140,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
140,4,Hypophagia,Appetite disorders,Appetite and general nutritional disorders,Metab,N
140,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
140,6,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
141,1,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
142,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
142,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
143,1,Brain oedema,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
143,2,Headache,Headaches NEC,Headaches,Nerv,N
143,3,Papilloedema,Optic disc abnormalities NEC,"Ocular structural change, deposit and degeneration NEC",Eye,N
143,4,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
144,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
144,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
144,3,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
144,4,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
144,5,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
144,6,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
144,7,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
144,8,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
144,9,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
145,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
145,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
145,3,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
145,4,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
146,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
146,2,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
146,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
146,4,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
146,5,Hydronephrosis,Renal obstructive disorders,Renal disorders (excl nephropathies),Renal,N
146,6,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
146,7,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
147,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
147,2,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
147,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
148,1,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
149,1,Poor peripheral circulation,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
150,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
150,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
151,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
152,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
153,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
153,2,Inadequate analgesia,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
153,3,Inhibitory drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
154,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
155,1,Dystonia,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
155,2,Muscle contractions involuntary,Neuromuscular disorders NEC,Neuromuscular disorders,Nerv,N
156,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
156,2,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
156,3,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
156,4,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
156,5,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
156,6,Headache,Headaches NEC,Headaches,Nerv,N
157,1,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
158,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
158,2,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
158,3,Judgement impaired,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
159,1,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
160,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
161,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
162,1,Dermatitis psoriasiform,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
162,2,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
162,3,Exfoliative rash,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
162,4,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
163,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
163,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
163,3,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
164,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
164,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
165,1,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
165,2,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
166,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
166,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
166,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
166,4,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
166,5,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
167,1,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
168,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
169,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
169,2,Myoclonus,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
170,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
171,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
171,2,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
171,3,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
171,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
172,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
173,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
173,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
173,3,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
173,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
173,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
173,6,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
173,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
174,1,Blood urine present,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
174,2,Renal pain,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
175,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
176,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
176,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
177,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
177,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
177,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
178,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
178,2,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
178,3,Headache,Headaches NEC,Headaches,Nerv,N
178,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
178,5,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
179,1,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
179,2,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
180,1,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
181,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
182,1,Acute left ventricular failure,Left ventricular failures,Heart failures,Card,Y
182,2,Hypertensive heart disease,Cardiac hypertensive complications,"Cardiac disorders, signs and symptoms NEC",Card,N
182,3,Myocardial ischaemia,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
182,4,Squamous cell carcinoma of the tongue,Lip and oral cavity neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
183,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
183,2,Headache,Headaches NEC,Headaches,Nerv,N
183,3,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,Y
183,4,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
184,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
184,2,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
185,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
185,2,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
185,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
185,4,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
186,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
187,1,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
188,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
188,2,Product residue present,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
189,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
189,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
189,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
190,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
190,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
190,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
190,4,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
190,5,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
191,1,Muscle contractions involuntary,Neuromuscular disorders NEC,Neuromuscular disorders,Nerv,N
191,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
192,1,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
192,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
193,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
193,2,Cardio-respiratory arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
194,1,Self-destructive behaviour,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
194,2,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
195,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
195,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
196,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
197,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
198,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
198,2,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
198,3,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
198,4,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
198,5,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
198,6,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
198,7,Wrong product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
199,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
199,2,Tongue ulceration,Tongue disorders,Tongue conditions,Gastr,N
200,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
200,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
201,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
201,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
201,3,Decreased eye contact,Psychiatric symptoms NEC,Psychiatric and behavioural symptoms NEC,Psych,N
201,4,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
201,5,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
201,6,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
201,7,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
201,8,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
201,9,Hypopnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
201,10,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
201,11,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
201,12,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
201,13,Oxygen saturation abnormal,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
201,14,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
201,15,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
201,16,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
201,17,Self-injurious ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
201,18,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
201,19,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
202,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
203,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
204,1,Oral discomfort,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
204,2,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
205,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
205,2,Hyperaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
205,3,Inadequate analgesia,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
206,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
207,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
207,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
208,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
208,2,Foetal growth restriction,Foetal growth complications,Foetal complications,Preg,N
209,1,Cystitis,Urinary tract infections,Infections - pathogen unspecified,Infec,N
209,2,Libido increased,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
209,3,Urinary tract disorder,Genital and urinary tract disorders NEC,Genitourinary tract disorders NEC,Renal,N
210,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
210,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
211,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
211,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
211,3,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
211,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
211,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
211,6,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
211,7,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
211,8,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
211,9,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
211,10,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
212,1,Death neonatal,Death and sudden death,Fatal outcomes,Genrl,Y
212,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
213,1,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
214,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
214,2,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
214,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
214,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
214,5,Yellow skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
215,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
215,2,Feeling of body temperature change,Feelings and sensations NEC,General system disorders NEC,Genrl,N
215,3,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
215,4,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
215,5,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
215,6,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
215,7,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
216,1,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
216,2,Libido increased,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
217,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
217,2,Distractibility,Cognitive and attention disorders and disturbances NEC,Cognitive and attention disorders and disturbances,Psych,N
217,3,"Hallucination, auditory",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
217,4,Schizophrenia,Schizophrenia NEC,Schizophrenia and other psychotic disorders,Psych,N
218,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
218,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
218,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
218,4,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
218,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
219,1,Ejaculation disorder,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
220,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
220,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
220,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
221,1,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
221,2,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
222,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
222,2,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
222,3,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
223,1,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
223,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
223,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
223,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
224,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
224,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
224,3,Hypoaesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
225,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
225,2,Headache,Headaches NEC,Headaches,Nerv,N
226,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
226,2,Feeling drunk,Feelings and sensations NEC,General system disorders NEC,Genrl,N
226,3,Inadequate analgesia,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
226,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
226,5,Proctalgia,Anal and rectal pains,Anal and rectal conditions NEC,Gastr,N
226,6,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
227,1,Reaction to excipient,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
227,2,Tongue blistering,Tongue signs and symptoms,Tongue conditions,Gastr,N
228,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
229,1,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
229,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
229,3,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
229,4,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
230,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
231,1,Injection site injury,Injection site reactions,Administration site reactions,Genrl,N
231,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
231,3,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,Y
232,1,Cancer pain,Oncologic complications and emergencies,Neoplasm related morbidities,Neopl,N
232,2,Pancreatic carcinoma,Pancreatic neoplasms malignant (excl islet cell and carcinoid),Gastrointestinal neoplasms malignant and unspecified,Neopl,N
233,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
233,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
234,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
235,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
235,2,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
236,1,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
236,2,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
236,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
236,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
236,5,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
236,6,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
236,7,Saliva altered,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
236,8,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
237,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
237,2,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
237,3,Retching,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
237,4,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
238,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
238,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
238,3,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
238,4,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
238,5,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
238,6,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
239,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
239,2,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
240,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
241,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
242,1,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
242,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
242,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
243,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
243,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
243,3,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
243,4,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
243,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
244,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
245,1,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
246,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
247,1,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
247,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
248,1,Coma scale abnormal,Neurologic diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
248,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
248,3,Miosis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
248,4,Myoclonus,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
248,5,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
248,6,Respiratory rate decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
248,7,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
248,8,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
249,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
250,1,Apnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
250,2,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
250,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
250,4,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
250,5,Mental status changes,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
250,6,Miosis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
250,7,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
250,8,Respiratory rate decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
251,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
252,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
253,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
253,2,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
254,1,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
255,1,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
255,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
256,1,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
257,1,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
258,1,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
259,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
259,2,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
260,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
261,1,Ventricular fibrillation,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
261,2,Ventricular fibrillation,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
262,1,Sexual dysfunction,Sexual function and fertility disorders NEC,Sexual function and fertility disorders,Repro,N
263,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
264,1,Drug withdrawal convulsions,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
264,2,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
264,3,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
264,4,Sneezing,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
264,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
264,6,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
264,7,Yawning,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
265,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
265,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
266,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
266,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
266,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
266,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
266,5,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
267,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
267,2,Peripheral coldness,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
268,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
268,2,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
269,1,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
269,2,Acute psychosis,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
269,3,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
269,4,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
269,5,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
269,6,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
269,7,Eating disorder,Eating disorders NEC,Eating disorders and disturbances,Psych,N
269,8,"Hallucination, tactile",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
269,9,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
269,10,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
270,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
270,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
270,3,Tooth disorder,Dental disorders NEC,Dental and gingival conditions,Gastr,N
271,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
271,2,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
272,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
272,2,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
273,1,Product residue present,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
273,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
274,1,Acute pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
275,1,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
275,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
275,3,Retching,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
275,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
276,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
276,2,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
276,3,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
277,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
278,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
279,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
280,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
280,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
280,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
281,1,Food craving,Appetite disorders,Appetite and general nutritional disorders,Metab,N
282,1,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
282,2,Drug withdrawal convulsions,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
283,1,Alcohol abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
283,2,Alcohol detoxification,Drug withdrawal therapies,Therapeutic procedures and supportive care NEC,Surg,N
283,3,Hepatic enzyme abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
283,4,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
284,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
284,2,Circumstance or information capable of leading to medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
284,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
284,4,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
284,5,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
284,6,Malabsorption,Malabsorption syndromes,Malabsorption conditions,Gastr,N
284,7,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
284,8,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
284,9,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
284,10,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
284,11,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
285,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
285,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
286,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
287,1,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
287,2,Decreased activity,Asthenic conditions,General system disorders NEC,Genrl,N
287,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
287,4,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
287,5,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
287,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
287,7,Yawning,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
288,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
289,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
289,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
290,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
291,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
291,2,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
291,3,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
291,4,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
291,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
292,1,Chronic kidney disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
292,2,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
292,3,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
292,4,Sedation complication,Anaesthetic and allied procedural complications,Procedural related injuries and complications NEC,Inj&P,N
293,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
293,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
293,3,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
294,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
295,1,Altered state of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
295,2,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
295,3,Gastric haemorrhage,Gastric and oesophageal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
295,4,Gastric perforation,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
295,5,Intra-abdominal haematoma,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
295,6,Oesophagitis,Oesophagitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
295,7,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
295,8,Pneumoperitoneum,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
295,9,Procedural pain,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
295,10,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
295,11,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
296,1,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
297,1,Hepatitis acute,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
298,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
299,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
299,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
300,1,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,Y
300,2,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
300,3,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
301,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
301,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
302,1,Aspiration,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
302,2,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
303,1,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
303,2,Limb deformity,Extremity deformities,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
303,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
304,1,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
305,1,Anaphylactic shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
305,2,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
305,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
306,1,Apnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
306,2,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
307,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
307,2,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
307,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
307,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
307,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
307,6,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
307,7,Tachypnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
308,1,Glossodynia,Tongue signs and symptoms,Tongue conditions,Gastr,N
308,2,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
309,1,Derealisation,Perception disturbances NEC,Disturbances in thinking and perception,Psych,N
309,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
309,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
309,4,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
309,5,Product taste abnormal,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
309,6,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
309,7,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
309,8,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
310,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
311,1,Compartment syndrome,Myopathies,Muscle disorders,Musc,N
311,2,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
311,3,Reperfusion injury,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
312,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
313,1,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
313,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
313,3,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
313,4,Miosis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
313,5,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
313,6,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
313,7,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
313,8,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
314,1,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
314,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
315,1,Cardio-respiratory arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
315,2,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
316,1,Axillary pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
316,2,Brief psychotic disorder with marked stressors,Brief psychotic disorder,Schizophrenia and other psychotic disorders,Psych,N
316,3,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
316,4,Death,Death and sudden death,Fatal outcomes,Genrl,Y
316,5,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
316,6,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
316,7,Product prescribing issue,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
317,1,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
317,2,Idiopathic neutropenia,Neutropenias,White blood cell disorders,Blood,N
318,1,Respiratory tract oedema,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
319,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
320,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
321,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
321,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
322,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
322,2,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
322,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
323,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
323,2,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
324,1,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
324,2,Peripheral coldness,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
325,1,Brain stem stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
325,2,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
325,3,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
325,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
325,5,Eyelid ptosis,Eyelid movement disorders,Ocular neuromuscular disorders,Eye,N
325,6,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
325,7,Ophthalmoplegia,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
325,8,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
325,9,Ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
326,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
327,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
327,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
327,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
328,1,Delirium,Deliria,Deliria (incl confusion),Psych,N
329,1,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
329,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
329,3,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
330,1,Coma scale abnormal,Neurologic diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
330,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
330,3,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
331,1,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
332,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
332,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
332,3,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
333,1,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
334,1,Drug effect less than expected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
334,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
335,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
336,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
337,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
337,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
337,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
337,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
338,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
338,2,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
338,3,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
338,4,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
338,5,Dental caries,Dental and periodontal infections and inflammations,Dental and gingival conditions,Gastr,N
338,6,Dizziness postural,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
338,7,Headache,Headaches NEC,Headaches,Nerv,N
338,8,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
338,9,Urinoma,Genital and urinary tract disorders NEC,Genitourinary tract disorders NEC,Renal,N
339,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
339,2,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
339,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
339,4,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
339,5,Sneezing,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
340,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
341,1,Skin erosion,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
341,2,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
342,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
342,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
343,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
343,2,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
344,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
345,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
345,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
345,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
345,4,Product prescribing issue,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
346,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
347,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
347,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
347,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
347,4,Product prescribing issue,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
